Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Ecofibre Ltd through its subsidiaries is engaged in three business lines including Ananda Health, Ananda Food and Hemp Black. Amanda Health includes Production and sale of hemp related nutraceutical products focused on the US. Ananda Food includes Production and sale of hemp related food products in Australia. Hemp Black includes the development of hemp related fibreproducts globally.
|25 Oct 2021||$0.79||$0.01||1.28%||77,942||$0.81||$0.82||$0.78|
|22 Oct 2021||$0.78||$-0.02||-2.50%||176,672||$0.81||$0.81||$0.78|
|21 Oct 2021||$0.80||$-0.03||-3.59%||253,323||$0.85||$0.85||$0.78|
|20 Oct 2021||$0.84||$-0.06||-6.74%||105,233||$0.89||$0.89||$0.84|
|19 Oct 2021||$0.89||$0.07||8.48%||145,802||$0.83||$0.90||$0.83|
|18 Oct 2021||$0.83||$-0.03||-3.53%||323,548||$0.85||$0.86||$0.82|
|15 Oct 2021||$0.85||$0.03||3.66%||126,728||$0.82||$0.85||$0.81|
|14 Oct 2021||$0.82||$-0.02||-2.38%||343,205||$0.84||$0.84||$0.81|
|13 Oct 2021||$0.84||$0.03||3.68%||40,845||$0.82||$0.84||$0.82|
|12 Oct 2021||$0.82||$-0.05||-5.81%||74,701||$0.86||$0.88||$0.82|
|11 Oct 2021||$0.86||$0.00||0.00%||4,674||$0.86||$0.86||$0.84|
|08 Oct 2021||$0.86||$0.04||4.88%||84,041||$0.83||$0.86||$0.83|
|07 Oct 2021||$0.82||$0.01||1.23%||62,070||$0.81||$0.84||$0.81|
|06 Oct 2021||$0.81||$0.01||1.24%||43,863||$0.81||$0.83||$0.81|
|05 Oct 2021||$0.81||$-0.02||-2.41%||92,047||$0.83||$0.83||$0.81|
|04 Oct 2021||$0.83||$0.02||2.47%||32,261||$0.82||$0.85||$0.82|
|01 Oct 2021||$0.81||$-0.03||-3.55%||100,226||$0.86||$0.87||$0.81|
|30 Sep 2021||$0.85||$0.00||0.00%||25,501||$0.85||$0.85||$0.82|
|29 Sep 2021||$0.85||$0.01||1.19%||124,992||$0.85||$0.88||$0.83|
|28 Sep 2021||$0.84||$-0.01||-1.18%||48,437||$0.85||$0.88||$0.83|
|11 Dec 2020||Eric Tse Wang||Buy||350||$745,182||
|Mr Barry Martin Lambert||Non-Executive ChairmanNon-Executive Director||Oct 2017||
Mr Lambert was also asked to serve as Chairman of Class Limited and subsequently took Class through to listing on the ASX. Barry founded ASX listed company, Count Limited in 1980. In 2016 and 2017, Barry and Joy Lambert made donations to establish the Lambert Initiative at Sydney University and Lambert Center at Thomas Jefferson University, respectively. Both entities are focused on the research and education of medicinal cannabis and hemp. In 2017, Barry resigned as Chairman of Class Limited.
|Ms Vanessa Miscamble Wallace||Non-Executive Deputy ChairmanNon-Executive Director||Jul 2021||
Ms Wallace is an experienced director and has gained experience working as a director of listed and non-listed companies including Wesfarmers Ltd, SEEK Ltd, Doctor Care Anywhere PLC and Palladium Holdings Pty Ltd. Her executive career includes almost 30 years as a strategy management consultant, where she focused on financial services, health and consumer product industries, including co-leading the Booz & Company business in Japan for 4 years. Earlier in her career she was a Portfolio Manager with Investment Bank Schroders. Ms Wallace is an early-stage investor in the health sector and the founding Chairman of Australian digital health & biotechnology business, Drop Bio Pty Ltd.
|Professor Bruce Gregory Robinson||Non-Executive Director||Mar 2021||
Prof Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlear, an ASX listed global hearing implants business; MaynePharma, an ASX listed pharmaceutical manufacturer; and QBiotics, a drug development company. Since 2015 Prof Robinson has also chaired the Australian Government's National Health and Medical Research Council, and the Medical Benefits Schedule Review Task Force. His prior professional experience includes Dean of University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. The summary of his experience is as follows: 2015 - present: Chair of the National Health and Medical Research Council; 2015 - present: Chair of the Medical Benefits Schedule Review Taskforce; 2007 - 2016: Dean, Sydney Medical School; 1998 - 2006: Head, Division of Medicine, Royal North Shore Hospital; 1990 - 2008: Head, Cancer Genetics Laboratory, Kolling Institute for Medical Research. Boards experience includes : Cochlear, 2015 - present; QBiotics, 2015 - present; MaynePharma, 2014 - present; and Woolcock Institute, 2006 - present.
|Mr Jonathan (Jon) Peter Meadmore||Non-Executive Director||Oct 2017||
Mr Meadmore is a Brisbane-based partner of law firm, Colin Biggers & Paisley. He is the joint leader of the corporate group, having practiced law for over 25 years.
|Mr Eric Tse Wang||Chief Executive OfficerManaging Director||Nov 2015||
Mr Wang has over 25 years of leadership and executive management experience, both as an officer in the United States Army and as a financial services executive in Australia. Prior to joining Ecofibre, Eric served as Captain and Apache pilot in the US Army for eight years in a range of roles, including Troop Commander, Operations Officer, Executive Officer and Personnel Officer in the United States and Europe.
|Ms Kristi Woolrych||Non-Executive Director||Oct 2020||
Ms Woolrych has over 20 years' experience in brand strategy, acquisition, retention, customer experience, eCommerce and retail marketing in a various of industries. She is currently the Chief Marketing Officer for KFC in Australia and New Zealand. Her experience include at KFC across the last two years and brand performance, resulting in APAC Effie Awards for Brand of the Year and Marketing Team of the Year in 2020. Prior to KFC, Ms Woolrych worked at Suncorp for over a decade, where she was promoted to the position of Executive General Manager, Brand and Marketing. During her carree she holds following position: 2018-Present Chief Marketing Officer, KFC SOPAC; 2016-2018 Executive General Manager Brand and Marketing, Suncorp; 2015-2016 Executive General Manager Group Marketing, Suncorp; 2013-2015 Executive Manager Brand and Customer Strategy, Suncorp; 2010-2013 Executive Manager Strategic Marketing and Insights, Suncorp; 2007-2010 Executive Manager Digital Marketing, Suncorp; and Other Experience MojoPartners (Publicis); Clemenger BBDO. She has completed a range of postgraduate programs including the Harvard Business School Digital Masterclass, INSEAD CMO Academy and Australian Marketing Institute Advanced Strategic Planning.
|Mr Jonathan Cedric Mengel Brown||Chief Financial OfficerCompany Secretary||Jan 2021||
|Ms Robin Sheldon||General CounselJoint Company Secretary||Jan 2021||
|Jonathan Cedric Mengel Brown||Chief Financial OfficerCompany Secretary||
|Robin Sheldon||General CounselJoint Company Secretary||
|Barjoy Pty Ltd||37,688,454||11.05%|
|Barry Martin Lambert & Joy Wilma Lillian Lambert||34,497,242||10.12%|
|Phil Warner Pty Ltd||32,481,381||9.52%|
|HSBC Custody Nominees (Australia) Limited||25,820,376||7.57%|
|Freshwater Superannuation Fund Pty Limited||20,089,149||5.89%|
|Kylie Warner Pty Ltd||16,340,072||4.79%|
|Thomas Jefferson University||12,178,259||3.57%|
|Citicorp Nominees Pty Limited||7,664,587||2.25%|
|Pacific Custodians Pty Limited (Employee Securities Tst Unallocated A/C)||7,200,000||2.11%|
|Pacific Custodians Pty Limited (Employee Securities Tst A/C)||6,909,286||2.03%|
|Wow Corporate Pty Ltd||6,648,700||1.95%|
|Manderrah Pty Limited||5,243,369||1.54%|
|Walling Pty Limited||4,850,181||1.42%|
|National Nominees Limited||3,163,706||0.93%|
|Yarrawonga Holdings Pty Limited (Yarrawonga Super Fund A/C)||3,048,553||0.89%|
|Troncell Pty Ltd||2,922,078||0.86%|